Notably, we observed that m6A “writers” METTL3 and METTL14 mRNA levels were respectively decreased by ~75% and ~49% in tumor-infiltrating NK cells of HCC patients (Fig. 1a). The gene discussed is METTL3; the disease is hepatocellular carcinoma.